US genomic cancer profiling firm FMI heads to China, where access to new therapies lags By: CNBC.com News June 13, 2017 at 00:41 AM EDT Roche-backed Foundation Medicine will bring its genomic sequencing of tumors to China in the third quarter. Read More >> Related Stocks: Foundation Medicine Rogers Corp